Research | OneLook Acronym Finder |
Serial Number | 87519680 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Christina M. Licursi, Esq. |
Attorney Docket Number | A119620010US |
Law Office Assigned | L10 |
Employee Name | PAQUIN, SAMUEL ROBERT |
2017-07-07 | Application Filed |
2017-12-05 | Published for Opposition |
2018-01-30 | Location: INTENT TO USE SECTION |
2018-09-03 | Abandon |
2018-09-03 | Status: Dead/Abandoned |
2018-09-04 | Transaction Date |
Owner: | Axcella Health Inc. |
Address | Third Floor 840 Memorial Drive Cambridge DE 02139 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0011 | Chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in scientific and medical research; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, and nutrients and nutritive products for use in the manufacture of beverages, food products and food supplements for human and non-human use; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, and muscle, bones, joints, and whole body movement; chemical and biochemical compounds, proteins, polypeptides, peptides, amino acids, vitamins, minerals, and nutrients and nutritive products being an ingredient in the manufacture of pharmaceutical preparations for the treatment or prevention of muscle loss, metabolic conditions and diseases, gastrointestinal conditions and diseases, neurological conditions and diseases, cancer, osteoporosis, inflammatory conditions and diseases, genetic conditions and diseases, muscle diseases and disorders, hepatic conditions and diseases, fibrosis, malnutrition, atrophic diseases and conditions, epilepsy, sarcopenia, myopathies, neuropathies, neurodegenerative diseases, traumatic brain injury, concussion, movement disorders, dystrophies, anemias, and orphan diseases; chemical and biochemical compounds, proteins, polypeptides and peptides, amino acids, vitamins, minerals, nutrients and nutritive products, and pharmaceutical excipients for in vitro medical research and in vivo scientific research |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-07-11 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-07-14 | 2 NWOS I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2017-09-20 | 3 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2017-09-20 | 4 ARAA I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2017-10-03 | 5 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-10-06 | 6 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-10-06 | 7 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-10-06 | 8 GNRN O:Outgoing Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2017-10-11 | 9 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2017-10-11 | 10 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2017-10-11 | 11 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2017-10-11 | 12 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-10-11 | 13 CNSA P: |
ASSIGNED TO LIE | 2017-10-27 | 14 ALIE A:Allowance for Publication |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-11-15 | 15 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2017-12-05 | 16 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-12-05 | 17 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-01-30 | 18 NOAM E:E-Mail |
ABANDONMENT - NO USE STATEMENT FILED | 2018-09-03 | 19 ABN6 S: |
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2018-09-04 | 20 MAB6 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.